SIGA Technologies (SIGA) Soars 29% as WHO Declares Monkeypox a Public Health Emergency

SIGA Technologies (SIGA) rose 29% as concerns over Monkeypox rises. The World Health Organization (WHO) has recently declared Monkeypox a public health emergency of global concern, which is the highest alert level that WHO uses.

Investors have flocked to SIGA, due to the Company’s lead product TPOXX, an oral drug for the treatment of human smallpox caused by the variola virus. Monkeypox is in the same virus family as smallpox, but with milder symptoms.

ABOUT SIGA TECHNOLOGIES, INC. and TPOXX®

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Our lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the US maintains a supply of TPOXX under Project BioShield. The oral formulation of TPOXX was approved by the FDA for the treatment of smallpox in 2018. The full label is available by clicking here. Oral tecovirimat received approval from the European Medicines Agency (EMA) in 2022. The EMA approval includes labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox. The full label is available by clicking here. In September 2018, SIGA signed a contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, for additional procurement and development related to both oral and intravenous formulations of TPOXX. For more information about SIGA, please visit www.siga.com.

 

About the Author

SIGA Technologies (SIGA) Soars 29% as WHO Declares Monkeypox a Public Health Emergency

Editor Investors Prism